文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

依托咪酯与氯胺酮对急诊老年患者插管期低血压的影响

The effect between etomidate and ketamine on peri-intubation hypotension in elderly patients in the emergency department.
PubMed 文献 · Am J Emerg Med · 2025-05-16
一句话结论急诊老年患者单用依托咪酯或氯胺酮诱导插管,插管期低血压与28天死亡率无显著差异。

这项前瞻性观察性倾向匹配队列研究在2022年3月23日至2023年9月30日期间于两个急诊中心纳入418例65岁及以上需气管插管的患者,比较单用依托咪酯或氯胺酮诱导对插管期低血压(PIH)及28天死亡率的影响。倾向匹配后222例患者中,依托咪酯组PIH发生率为44.1%,氯胺酮组为53.2%(风险差9.1%,95%CI -4.1至22.1,p=0.179),无统计学显著差异。28天死亡率依托咪酯组36.0% vs 氯胺酮组25.2%(HR 0.66,95%CI 0.41-1.07,p=0.095),亦无显著差异。但在发生PIH并需使用血管升压药的患者中,氯胺酮与较低的28天死亡风险相关(校正HR 0.59,95%CI 0.36-0.97,p=0.034)。在休克指数≥0.9的患者中,两种药物诱导剂量越高,PIH概率均增加。

要点

  • 倾向匹配后222例老年急诊插管患者中,PIH发生率依托咪酯组44.1% vs 氯胺酮组53.2%,风险差9.1%(95%CI -4.1至22.1,p=0.179),无统计学显著差异。
  • 28天死亡率依托咪酯组36.0% vs 氯胺酮组25.2%(HR 0.66,95%CI 0.41-1.07,p=0.095),无统计学显著差异。
  • 在发生PIH并需血管升压药的患者中,氯胺酮组28天死亡风险较低(校正HR 0.59,95%CI 0.36-0.97,p=0.034)。
  • 休克指数≥0.9的患者中,依托咪酯和氯胺酮诱导剂量越高,PIH概率均增加。

适用人群与场景

  • 65岁及以上、需气管插管、单用依托咪酯或氯胺酮作为诱导剂的急诊患者。
  • 研究于两个急诊中心开展,时间为2022年3月23日至2023年9月30日。

诊断标准与关键阈值

  • 插管期低血压(PIH)定义:诱导后30分钟内收缩压较基线下降超过20%,或收缩压<100 mmHg(伴或不伴液体复苏),或开始或增加血管升压药治疗。

研究设计与关键结果

  • 研究类型:前瞻性、观察性、倾向匹配队列研究,两个急诊中心,共纳入418例患者,倾向匹配后222例(1:1匹配)。
  • 主要终点:PIH发生率依托咪酯组44.1% vs 氯胺酮组53.2%,风险差9.1%(95%CI -4.1至22.1,p=0.179),无统计学显著差异。
  • 次要终点:28天死亡率依托咪酯组36.0% vs 氯胺酮组25.2%(HR 0.66,95%CI 0.41-1.07,p=0.095),无统计学显著差异。
  • 亚组分析:发生PIH并需血管升压药的患者中,氯胺酮组28天死亡风险较低(校正HR 0.59,95%CI 0.36-0.97,p=0.034)。
  • 休克指数≥0.9的患者中,两种药物诱导剂量越高,PIH概率均增加(采用分数多项式回归评估)。

证据类型、等级与局限

  • 证据类型:前瞻性观察性倾向匹配队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文结论:在急诊老年患者中,单用依托咪酯或氯胺酮诱导插管对PIH和28天死亡率无统计学显著差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Peri-intubation hypotension (PIH) is associated with increased mortality. Etomidate and ketamine are commonly used as induction agents for tracheal intubation in the emergency department (ED) due to their favorable hemodynamic profiles. However, the effects of these agents on PIH remain controversial, and data on elderly patients are limited. This study aimed to compare the effects of etomidate and ketamine on PIH and 28-day mortality.

METHODS: A prospective, observational, propensity-matched cohort study was performed across two ED centers between March 23, 2022, and September 30, 2023. Patients aged 65 years and older requiring tracheal intubation and receiving either etomidate or ketamine as a single induction agent were included. The primary outcome was the incidence of PIH within 30 min post-induction, comparing etomidate and ketamine. PIH was defined as a systolic blood pressure (SBP) decrease of more than 20 % from baseline, SBP <100 mmHg (with or without fluid resuscitation), or the initiation or increased dose of vasopressor therapy. Secondary outcomes included 28-day mortality and subgroup analysis evaluating the effect of induction dose on PIH in patients with a shock index (SI) ≥0.9. Statistical analyses included a chi-square test to compare PIH incidence and Cox regression analysis to assess the association between induction agents and 28-day mortality. Multivariable Cox regression was adjusted for mortality by vasopressor initiation or escalation. Fractional polynomial regression was used to evaluate the relationship between induction agent dose and PIH.

RESULTS: A total of 418 patients were included in the analysis, with 222 patients matched in a 1:1 propensity score analysis. The incidence of PIH was 44.1 % in the etomidate group and 53.2 % in the ketamine group (risk difference 9.1 %, 95 % confidence interval [CI] -4.1 to 22.1, p = 0.179). 28-day mortality was 36.0 % in the etomidate group and 25.2 % in the ketamine group (hazard ratio [HR] 0.66, 95 % CI 0.41-1.07, p = 0.095). However, in patients who developed PIH and required vasopressors, ketamine was associated with a lower risk of 28-day mortality (adjusted HR 0.59, 95 % CI 0.36-0.97, p = 0.034). Among patients with SI ≥0.9, a higher induction agent dose was associated with an increased probability of PIH for both etomidate and ketamine.

CONCLUSION: There was no statistically significant difference in PIH and 28-day mortality between etomidate and ketamine as a single induction agent in elderly patients in the ED.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Supatanakij P, Mungjadetanadee T, Boonyok N, et al. The effect between etomidate and ketamine on peri-intubation hypotension in elderly patients in the emergency department. Am J Emerg Med. 2025. PMID: 40403367. doi:10.1016/j.ajem.2025.05.021

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。